Dive Brief:
- SAP has launched two new software products, Foundation for Health and Medical Research Insights, both built on top of its HANA in-memory computing platform.
- The former is a warehouse for clinical and genomic data and the later is an application that enables users to analyze data for research, population health, clinical trials, and drug development.
- Dr. David Delaney, chief medical officer of SAP said, "Our vision is really to create a health network enabling personalized medicine."
Dive Insight:
Early users of the new software products include large medical consortiums such as the American Society of Clinical Oncology (ASCO) and the National Center for Tumor Diseases. ASCO worked with SAP to develop the CancerLinQ platform to assist physicians in accessing data sources to create personalized treatment programs. Major medical systems including Baylor, Johns Hopkins, and Sutter all utilize the company's HANA in-memory computing platform.
NIH announced plans to enroll one million participants in a new database that will utilize medical records, claims data, and mobile device data to correlated various health measures and environmental exposures with each participant's outcomes. The Precision Medicine Initiative's focus will be to accelerate new opportunities in cancer genomics and develop a long-term approach to all diseases, as previously reported by Healthcare Dive.
A recent Research and Markets report estimates the value of the global precision medicine market will hit $88 billion by 2022.